Document Classification

Section Type: RESULTS

Text: A comparison of treatment outcomes in the diabetic subgroup revealed that the combination therapy compared with heparin alone was associated with reductions in the incidence of the composite primary end point of death, myocardial infarction (MI), or refractory ischemia at 2, 7, 30, and 180 days (7. 7 % versus 8. 3 %, 14. 8 % versus 21. 8 %, 20. 1 % versus 29. 0 %, and 32. 0 % versus 39. 9 %, respectively ; P = NS) and in the incidence of MI or death (0. 0 % versus 3. 1 %, P : = 0. 03 ; 1. 2 % versus 9. 3 %, P : = 0. 005 ; 4. 7 % versus 15. 5 %, P : = 0. 002 ; and 11. 2 % versus 19. 2 %, P : = 0. 03).